Community/Retail

The authors note that this lack of inclusion can leave important safety and efficacy questions unanswered.

Levonorgestrel-releasing intrauterine devices were not found to increase women’s risks of these conditions.

Lawsuits were initiated against the pharmacy and prescriber.

According to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.

The FDA-approved treatment did not cause as many adverse events as immunotherapy when treating patients with multi-food allergy.

Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.

Gaps in education about biosimilars, particularly among pharmacists, patients, and prescribers, are a significant barrier to wider adoption.

The test results are available in as little as 20 minutes.

The long-term durability of response will be evaluated in the B-Sure trial (NCT04954859), which will enroll patients with hepatitis B virus (HBV) from B-Together (NCT04676724).

Curbing RSV and its complications can reduce health care costs associated with its treatment.

Currently, the agent is undergoing evaluation in a phase 2 clinical trial to determine its safety and efficacy.

Pharmacists’ expanded role comes at a cost, as they must now navigate conflicting laws, ethical dilemmas, and professional expectations while maintaining the integrity of their practice.

In a study of 5 different drugs, amlodipine was the only one to reduce hyperactivity in patients with attention-deficit hyperactivity disorder (ADHD).

SkinTE could aid Wagner grade 1 diabetic foot ulcers by regenerating and activating the tissues surrounding the wound to heal it completely.

This marks the first FDA-approved treatment for this rare lipid storage disease.

In children aged 1 to 3 years, the VP250 peanut patch was superior to placebo in the desensitization to peanuts and increasing the peanut dose that triggers allergic symptoms.

Treatment with semaglutide yielded superior effects on drinking outcomes compared with existing therapies to reduce alcohol cravings.

Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.

PfSPZ-LARC2 is a genetically engineered malaria vaccine that marks a significant step forward in combating malaria around the world.

Educating patients about lifestyle modifications is a critical part of preventing cerebrovascular events.

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

QPL use in the pharmacy setting may enhance patient engagement while allowing pharmacists to showcase their medication-related expertise.

Coinfection with RSV and hRV is linked to a higher prevalence of lower respiratory tract infections, according to new data.

Many patients may struggle to understand the complex immunization schedules compiled by the CDC.

Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.

All stakeholders should work together to determine and address drug shortages.